Thank you.
There have been extensive consultations over many years regarding the Patented Medicine Prices Review Board and specifically the regulations, which came into force in August 2019. Subsequent to that, there has been extensive consultation on the guidelines to implement those through the PMPRB in regard to the effect of the pandemic.
Furthermore, through the work of the Ministry of Health and the Ministry of Innovation, Science and Economic Development, we have been consulting the industry, patient groups and others on the life sciences sector in this country; rejuvenating the biomanufacturing sector, as outlined in the budget, with an investment of $2.2 billion; and working on critical elements, such as Dr. Strong referred to, in terms of clinical trials and regulatory systems.